Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Anika Therapeutics announces Canadian distribution agreement for Elevess
Bedford, Mass. - Anika Therapeutics has signed an agreement with Canderm Pharma, a skincare company in Canada, to distribute and market Elevess throughout Canada, BusinessWire reports.
Bedford, Mass.
- Anika Therapeutics has signed an exclusive agreement with Canderm Pharma, a skincare company in Canada, to distribute and market Elevess throughout Canada, BusinessWire reports.
Elevess is the first hyaluronic acid filler with lidocaine to be approved by the U.S. Food and Drug Administration.
Recent Videos
Related Content
